BAP1-Related Tumor Predisposition Syndrome
specificAn autosomal dominant inherited tumor predisposition syndrome caused by germline mutations in the BAP1 gene. Carriers are at an increased risk of developing various neoplasms including BAP1-inactivated melanocytoma, cutaneous melanoma, uveal melanoma, basal cell carcinoma, malignant mesothelioma, and clear cell renal cell carcinoma.
Top Centers for BAP1-Related Tumor Predisposition Syndrome
Ranked by research excellence score (trials · grants · publications). Methodology →
No centers currently specializing in this cancer type.
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →